Dr. William Jackson, M.D.
Claim this profileUniversity of Michigan Rogel Cancer Center
Affiliated Hospitals
University Of Michigan Rogel Cancer Center
University Of Michigan Comprehensive Cancer Center
Clinical Trials William Jackson, M.D. is currently running
Moderate vs Ultra-Hypofractionated Radiation
for Prostate Cancer
This trial compares the quality of life of prostate cancer patients treated with a short-term, high-dose radiation therapy to those treated with the standard, longer-term radiation therapy. The new method aims to reduce the number of treatments, making it easier for patients to complete their treatment and potentially improve their quality of life. This newer radiotherapy method for prostate cancer aims to shorten the treatment duration and improve patient convenience.
Recruiting
1 award
Phase 2
Stereotactic Radiation + Immunotherapy
for Kidney Cancer
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has spread from where it first started (primary site) to other places in the body (metastatic). Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses of radiation over a shorter period and cause less damage to normal tissue. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, avelumab, and pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving SABR in combination with standard of care immunotherapy may help shrink or stabilize the cancer in patients with renal cell cancer.
Recruiting
1 award
Phase 2
21 criteria
More about William Jackson, M.D.
Clinical Trial Related
4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments William Jackson, M.D. has experience with
- Moderately Hypo-fractionated Radiation Therapy
- Ultra-hypofractionated Radiation Therapy
- Abiraterone Acetate
- Leuprolide
- Niraparib
- Stereotactic Body Radiotherapy (SBRT)
Breakdown of trials William Jackson, M.D. has run
Prostate Cancer
Prostate Adenocarcinoma
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William Jackson, M.D. specialize in?
William Jackson, M.D. focuses on Prostate Cancer and Prostate Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved treating patients, or patients who are undergoing treatment.
Is William Jackson, M.D. currently recruiting for clinical trials?
Yes, William Jackson, M.D. is currently recruiting for 2 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that William Jackson, M.D. has studied deeply?
Yes, William Jackson, M.D. has studied treatments such as Moderately Hypo-fractionated Radiation Therapy, Ultra-hypofractionated radiation therapy, Abiraterone Acetate.
What is the best way to schedule an appointment with William Jackson, M.D.?
Apply for one of the trials that William Jackson, M.D. is conducting.
What is the office address of William Jackson, M.D.?
The office of William Jackson, M.D. is located at: University of Michigan Rogel Cancer Center, Ann Arbor, Michigan 98107 United States. This is the address for their practice at the University of Michigan Rogel Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.